You're offline — showing cached data
BibaMoney TVIJO AIOS NETWORK

Merck & Co., Inc.

MRK · NYSE
Healthcare · Drug Manufacturers - General
$145.27 -1.34% today
—Market cap
—P/E (TTM)
—Net margin
—Revenue / share

About Merck & Co., Inc.

Merck & Co., Inc. is a global healthcare company operating through two segments: Pharmaceuticals and Animal Health. The Pharmaceutical segment develops and markets human health products across therapeutic areas including oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes, as well as preventive vaccines for pediatric, adolescent, and adult populations. The Animal Health segment researches, develops, manufactures, and markets veterinary medicines and vaccines.

Why it matters

Merck is one of the largest pharmaceutical companies by revenue and is a major constituent of the healthcare sector in broad market indices. Its scale, broad therapeutic portfolio, and global vaccine and oncology franchises make it a widely followed name among investors tracking drug manufacturers. The company competes with other large-cap pharmaceutical firms across multiple therapeutic categories, and its results are influenced by patent expirations, clinical trial outcomes, regulatory decisions, and product demand.

Company site ↗

How we research MRK

Fundamentals like the ones above feed our fundamental screen — EPS acceleration, ROE and momentum∧quality — the one research class that survives walk-forward in our testing. We don’t issue price targets or buy/sell calls: see /edge for how rigorously (and how rarely) anything passes. This page is market data and research, not investment advice.

Data updated 18:00 UTC, 26 Oct 2026 · source: Financial Modeling Prep via Tvijo AIOS.